… The Selecting Therapeutic Targets in IBD (STRIDE) program was initiated by the … to a
position statement determining therapeutic targets for IBD to be used for a “treat-to-target” clinical …

… The group recommended that the primary therapeutic target in both UC and CD should
be the composite endpoint of both clinical/patient-reported outcome [PRO] and endoscopic …

… The STRIDE-II position statement, published in 2021 by the Selecting Therapeutic Targets
in Inflammatory Bowel Disease (STRIDE) initiative of the International Organisation for the …

… The ‘treat- to- target’ approach is characterised by a pre- specified realistic therapeutic target
… Evolving short- and long- term goals of management of inflammatory bowel diseases: get…

… select the best treat-to-target option or combinations and to guide treatment toward achieving
the short- and long- term therapeutic goals … be used to determine the optimal composition …

… independent of mucosal inflammation in pediatric inflammatory bowel disease [Citation20]. …
, as the authors suggest, should be considered a therapeutic target in CD [Citation67]. This …

… for ulcerative colitis and Crohn’s disease. Targets are predefined therapeutic goals demonstrated
to … The therapeutic goal of the study is endoscopic remission defined as Mayo score 0. …

… goal of this approach is to modify the natural history of inflammatory bowel diseases by trying
to block bowel … In this review, we will discuss the current recommended therapeutic targets, …

… management consensus (STRIDE) “Selecting therapeutic targets in IBD”, which was based
on both clinical and endoscopic objectives. This is where the concept of “treat to target” (T2T) …

… Organization for the Study of Inflammatory Bowel Disease, with the first iteration of the
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) guidelines published in …